/Companies

Meves Pharmaceuticals

New York, US · Founded 2016 · Delaware corporation

Find your way into Meves Pharmaceuticals

Sign up to see every warm intro you have to Meves Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Meves Pharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

RG
Rishi GuptaNamed on SEC filing
PB
Peter BarberNamed on SEC filing
JG
Joshua GrassNamed on SEC filing
BA
Ben AuspitzNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$10.9M disclosed across 1 round · 2018

▶$10.9MraisedMar 2018 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Rishi GuptaDirector
  • Peter BarberDirector
  • Joshua GrassExecutive Officer, Director
  • Ben AuspitzDirector
Offering amount
$30.9M
Amount sold
$10.9M
First sale
Mar 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Meves Pharmaceuticals raised?
Meves Pharmaceuticals has disclosed $10.9M raised across 1 round.
Where is Meves Pharmaceuticals headquartered?
Meves Pharmaceuticals is headquartered in New York, US.